High rates of advanced gastric cancer in community of Flushing, New York.
BACKGROUND
Gastric cancer remains a major public health issue and is a leading cause of death worldwide, accounting for 600,000 deaths annually. Over the last decades, there has been a steady decline in the incidence rates of gastric cancer. Furthermore, the incidence rates of gastric cancer in different parts of the country vary due to epidemiological and migration trends. Despite these trends, several studies that have continued to observe high rates of gastric cancer in populations that come from high-risk regions.


OBJECTIVE
The aim of the study was to describe the gastric cancer patients presenting NYHQ with an emphasis on those presenting at a young age and advanced disease. A subanalysis of the Asian population was also done, which is considered a high-risk group.


METHODS
Consecutive chart review of patients admitted with gastric cancer from January 2000 to August 2008 was extracted from the Oncology registry at NYHQ. Parameters that were evaluated were age, sex, race, type of gastric cancer, and stage of gastric cancer at initial presentation. The SAS/PC software package (SAS Institute Inc., Cary, NC) was employed for statistical analyses.


RESULTS
Four hundred fifty-seven patients were diagnosed with gastric cancer. Approximately one third of the total patients were younger than 60 years of age. Of the Asian patients, almost half the patients (48.8%) had advanced disease of which two thirds were under the age of 60 years.


CONCLUSIONS
The rates of advanced gastric cancer observed at NYHQ are significant and comparable to recent epidemiology literature on rates in Asian populations in Asia. Communities, like Flushing, NY, may benefit from early detection of gastric cancers, similar to those instituted in Japan and Taiwan.
Dinani
Amreen
A
Department of Medicine, New York Hospital Queens, New York, NY, USA. amreen.dinani@gmail.com
Desai
Amit
A
Kohn
Nina
N
Gutkin
Ellen
E
Nussbaum
Michel
M
Somnay
Kaumudi
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D044466:Asian People; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000208:ethnology / Q000401:mortality; D013997:Time Factors
JAMA. 2010 May 5;303(17):1723-8
20442388
Int J Cancer. 1999 Sep 24;83(1):18-29
10449602
Cancer Causes Control. 1999 Feb;10(1):77-83
10334646
Cancer. 2000 Nov 1;89(9):1883-92
11064344
Eur J Cancer. 1996 May;32A(5):761-71
9081351
Cancer Control. 2007 Jan;14(1):78-85
17242674
Eur J Cancer Prev. 1999 Jul;8(3):223-7
10443951
CA Cancer J Clin. 2007 Jul-Aug;57(4):190-205
17626117
Cancer Causes Control. 2007 Aug;18(6):585-93
17406989
J Gastrointest Surg. 2004 Mar-Apr;8(3):240-4
15019915
South Med J. 1993 Mar;86(3):302-4
8451669
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):15-8
8118379
Recent Results Cancer Res. 1998;154:298-305
10027010
Cancer Causes Control. 1998 Jan;9(1):1-2
9486457
Semin Oncol. 2004 Aug;31(4):450-64
15297938
Semin Radiat Oncol. 2002 Apr;12(2):111-27
11979413
Ann Oncol. 2010 Jan;21(1):152-60
19622590
Br J Surg. 1985 Apr;72(4):289-91
3986480
Cancer. 1972 May;29(5):1261-3
4336630
N Engl J Med. 2000 Jul 13;343(2):78-85
10891514
West J Med. 1991 Feb;154(2):172-4
2006563
Clin Gastroenterol Hepatol. 2006 Jun;4(6):709-16
16765306
Cancer. 1992 Jul 1;70(1):50-5
1606546
World J Gastroenterol. 2006 Jan 21;12(3):354-62
16489633
Lancet. 1997 May 24;349(9064):1498-504
9167458